BVF.SG - Valeant Pharma. Int. Inc. Regis
| Previous Close | 14.07 |
| Open | 13.98 |
| Bid | 14.33 x 100000 |
| Ask | 14.57 x 100000 |
| Day's Range | 13.92 - 14.48 |
| 52 Week Range | 7.86 - 20.20 |
| Volume | 0 |
| Avg. Volume | 359 |
| Market Cap | N/A |
| Beta | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- InvestorPlace•last month
5 Big Biotech Stocks to Buy Under $10
For investors, biotech stocks remain one of the most dynamic sectors out there. On one hand, you have some of the largest pharmaceutical firms on the planet with multi-billion-dollar blockbuster drugs filling their coffers. On the other, you have the more stereotypical “lotto ticket” biotech stocks of clinical or early production stage firms.
InvestorPlace•last monthHow Valeant Pharmaceuticals Intl Inc Can Give You a 750% Return
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) still has its share of detractors. Late last month Valeant stock came out with its quarterly confessional, which featured an improving and profitable bottom-line of 98-cents-per-share.
- InvestorPlace•2 months ago
Valeant Pharmaceuticals Intl Inc Stock Tumbles on Q4 Revenue Miss
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock took a hit today following the release of its earnings report for the fourth quarter of 2017. The big blow to VRX stock today was the company’s revenue of $2.16 billion for the fourth quarter of the year. It also came in below Wall Street’s revenue estimate of $2.18 billion for the quarter.
- InvestorPlace•2 months ago
Shopify Inc’s Problem Is It’s Still Not Making Money
It shows revenues of $222.8 million, nearly double the previous year’s $130 million, and a gross profit of $121 million. During my reporting career, I have seen several Canadian companies rise, and then fall, on their own hype.
- Reuters•9 months ago
Morning News Call Canadienne - Aout 8
Pour consulter la lettre d'information; cliquez sur le lien: http://share.thomsonreuters.com/assets/newsletters/Morning_News_Call/MNCCA_FR_08082017.pdf PRINCIPAUX INDICATEURS À L’AGENDA Pas d’indicateurs ...
- Reuters•11 months ago
Morning News Call Canadienne - Mai 9
Pour consulter la lettre d'information; cliquez sur le lien: http://share.thomsonreuters.com/assets/newsletters/Morning_News_Call/MNCCA_FR_05092017.pdf PRINCIPAUX INDICATEURS À L’AGENDA 08:30 Permis de ...
